Ondansetron ODT 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FE7Q4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,330
Award facts
- Contract value 100% obligated
- $21,329.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,329.66 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units). The contract, awarded on November 25, 2025, operates under a firm fixed-price structure with an ultimate completion date of November 26, 2025. This is a competitive award with no set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through the DLA Medical Supply Chain. The company's portfolio includes a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, and it maintains significant contract vehicles to support Defense Health Agency operations and other government healthcare systems globally. The Ondansetron ODT tablets being procured under this delivery order represent an antiemetic medication commonly utilized in military medical operations and federal healthcare settings.
Quick answers
Who was awarded contract SPE2DR26FE7Q4?
SPE2DR26FE7Q4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26FE7Q4 worth?
The government has obligated $21,330 on SPE2DR26FE7Q4.
Is contract SPE2DR26FE7Q4 an order under another contract?
Yes. SPE2DR26FE7Q4 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE7Q4 competed?
The extent of competition for SPE2DR26FE7Q4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award